EE200100403A - Indooli derivaadid ja nende kasutamine MCP-1 antagonistidena - Google Patents

Indooli derivaadid ja nende kasutamine MCP-1 antagonistidena

Info

Publication number: EE200100403A
Authority: EE; Estonia
Prior art keywords: mcp; antagonists; indole derivatives; indole; derivatives
Prior art date: 1999-02-05

Application number

EEP200100403A

Other languages

English (en)

Estonian (et)

Inventor

Wellington Faull Alan

Grant Kettle Jason

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-05

Filing date

2000-01-31

Publication date

2002-10-15

2000-01-31 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-10-15 Publication of EE200100403A publication Critical patent/EE200100403A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

EEP200100403A 1999-02-05 2000-01-31 Indooli derivaadid ja nende kasutamine MCP-1 antagonistidena EE200100403A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9902461.4A GB9902461D0 (en)	1999-02-05	1999-02-05	Chemical compounds
PCT/GB2000/000265 WO2000046196A1 (en)	1999-02-05	2000-01-31	Indole derivatives and their use as mcp-1 antagonists

Publications (1)

Publication Number	Publication Date
EE200100403A true EE200100403A (et)	2002-10-15

Family

ID=10847084

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100403A EE200100403A (et)	1999-02-05	2000-01-31	Indooli derivaadid ja nende kasutamine MCP-1 antagonistidena

Country Status (27)

Country	Link
US (1)	US6737435B1 (xx)
EP (1)	EP1150952B1 (xx)
JP (1)	JP2002536359A (xx)
KR (1)	KR20010094755A (xx)
CN (1)	CN1339025A (xx)
AR (1)	AR022461A1 (xx)
AT (1)	ATE280757T1 (xx)
AU (1)	AU770856B2 (xx)
BR (1)	BR0007984A (xx)
CA (1)	CA2356898A1 (xx)
CZ (1)	CZ20012807A3 (xx)
DE (1)	DE60015296T2 (xx)
EE (1)	EE200100403A (xx)
GB (1)	GB9902461D0 (xx)
HU (1)	HUP0105079A3 (xx)
ID (1)	ID30401A (xx)
IL (1)	IL144611A0 (xx)
IS (1)	IS5980A (xx)
MY (1)	MY133209A (xx)
NO (1)	NO20013809L (xx)
NZ (1)	NZ512680A (xx)
PL (1)	PL350184A1 (xx)
RU (1)	RU2235090C2 (xx)
SK (1)	SK11152001A3 (xx)
TR (1)	TR200102233T2 (xx)
WO (1)	WO2000046196A1 (xx)
ZA (1)	ZA200105311B (xx)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9716657D0 (en)	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
GB9902461D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB0000625D0 (en) *	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
GB0000626D0 (en) *	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
PL366068A1 (en)	2000-10-10	2005-01-24	Smithkline Beecham Corporation	Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents
CA2432369A1 (en)	2000-12-20	2002-08-08	Bristol-Myers Squibb Pharma Company	Cyclic derivatives as modulators of chemokine receptor activity
JP2005506949A (ja)	2000-12-20	2005-03-10	ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー	ケモカイン受容体の調節剤としてのジアミン
KR101255356B1 (ko)	2002-06-12	2013-04-17	케모센트릭스, 인크.	염증 및 면역 질병의 치료를 위한 ｃｃｒ１ 길항물질로서사용하기 위한 1-아릴-4-치환된 피페라진 유도체
US7842693B2 (en)	2002-06-12	2010-11-30	Chemocentryx, Inc.	Substituted piperazines
US7589199B2 (en)	2002-06-12	2009-09-15	Chemocentryx, Inc.	Substituted piperazines
TW200508224A (en)	2003-02-12	2005-03-01	Bristol Myers Squibb Co	Cyclic derivatives as modulators of chemokine receptor activity
RU2366655C2 (ru)	2003-03-14	2009-09-10	Оно Фармасьютикал Ко., Лтд.	Азотсодержащие гетероциклические производные и лекарственные средства, содержащие их в качестве активного ингредиента
EP1619193A4 (en)	2003-04-18	2010-08-11	Ono Pharmaceutical Co	SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF
US7230133B2 (en)	2003-05-01	2007-06-12	Bristol-Myers Squibb Company	Malonamides and malonamide derivatives as modulators of chemokine receptor activity
US7291615B2 (en)	2003-05-01	2007-11-06	Bristol-Myers Squibb Company	Cyclic derivatives as modulators of chemokine receptor activity
US7732162B2 (en)	2003-05-05	2010-06-08	Probiodrug Ag	Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
US7479496B2 (en)	2004-02-19	2009-01-20	Bristol-Myers Squibb Company	Substituted spiro azabicyclics as modulators of chemokine receptor activity
US7288563B2 (en)	2004-02-19	2007-10-30	Bristol-Myers Squibb Company	Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US7230022B2 (en)	2004-02-19	2007-06-12	Bristol-Myers Squibb Company	Substituted fused bicyclic amines as modulators of chemokine receptor activity
US7381738B2 (en)	2004-02-19	2008-06-03	Bristol-Myers Squibb Company	Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US7435831B2 (en)	2004-03-03	2008-10-14	Chemocentryx, Inc.	Bicyclic and bridged nitrogen heterocycles
WO2005084667A1 (en)	2004-03-03	2005-09-15	Chemocentryx, Inc.	Bicyclic and bridged nitrogen heterocycles
US8481035B2 (en)	2004-04-27	2013-07-09	Northwestern University	Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A
US20080187508A1 (en) *	2004-09-08	2008-08-07	Boys Town National Research Hospital	Treatment of Golmerular Basement Membrane Disease Involving Matrix Metalloproteinase-12
CN101775013A (zh)	2004-09-13	2010-07-14	小野药品工业株式会社	含氮杂环衍生物及含有其作为活性成分的药物
JPWO2006129679A1 (ja)	2005-05-31	2009-01-08	小野薬品工業株式会社	スピロピペリジン化合物およびその医薬用途
FR2890071B1 (fr)	2005-08-30	2007-11-09	Fournier Sa Sa Lab	Nouveaux composes de l'indole
PT1942108E (pt)	2005-10-28	2013-10-24	Ono Pharmaceutical Co	Composto com um grupo básico e a sua utilização
WO2007058322A1 (ja)	2005-11-18	2007-05-24	Ono Pharmaceutical Co., Ltd.	塩基性基を含有する化合物およびその用途
CA2631128A1 (en)	2005-12-09	2007-06-14	F. Hoffmann-La Roche Ag	Tricyclic amide derivatives useful for treating obesity
EP1990335A4 (en) *	2006-03-02	2009-11-11	Astellas Pharma Inc	17-BETA-HSD-type-5 INHIBITOR
CA2644368A1 (en)	2006-03-10	2007-09-20	Ono Pharmaceutical Co., Ltd.	Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
US8618122B2 (en)	2006-05-16	2013-12-31	Ono Pharmaceutical Co., Ltd.	Compound having acidic group which may be protected, and use thereof
DE102006033572A1 (de)	2006-07-20	2008-01-24	Bayer Cropscience Ag	N'-Cyano-N-halogenalkyl-imidamid Derivate
WO2008016006A1 (fr)	2006-07-31	2008-02-07	Ono Pharmaceutical Co., Ltd.	Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation
US20080076120A1 (en) *	2006-09-14	2008-03-27	Millennium Pharmaceuticals, Inc.	Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders
JP5379692B2 (ja)	2006-11-09	2013-12-25	プロビオドルグエージー	潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体
EP2091948B1 (en)	2006-11-30	2012-04-18	Probiodrug AG	Novel inhibitors of glutaminyl cyclase
EP2117540A1 (en)	2007-03-01	2009-11-18	Probiodrug AG	New use of glutaminyl cyclase inhibitors
WO2008128985A1 (en)	2007-04-18	2008-10-30	Probiodrug Ag	Thiourea derivatives as glutaminyl cyclase inhibitors
PT2250161E (pt) *	2008-01-18	2014-01-21	Atopix Therapeutics Ltd	Compostos tendo atividade antagonista de crth2
WO2010043396A1 (en) *	2008-10-16	2010-04-22	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
WO2010129351A1 (en)	2009-04-28	2010-11-11	Schepens Eye Research Institute	Method to identify and treat age-related macular degeneration
FR2950053B1 (fr)	2009-09-11	2014-08-01	Fournier Lab Sa	Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
WO2011029920A1 (en)	2009-09-11	2011-03-17	Probiodrug Ag	Heterocylcic derivatives as inhibitors of glutaminyl cyclase
WO2011107530A2 (en)	2010-03-03	2011-09-09	Probiodrug Ag	Novel inhibitors
ES2481823T3 (es)	2010-03-10	2014-07-31	Probiodrug Ag	Inhibidores heterocíclicos de glutaminil ciclasa (QC, EC 2.3.2.5)
EP2560953B1 (en)	2010-04-21	2016-01-06	Probiodrug AG	Inhibitors of glutaminyl cyclase
KR101350077B1 (ko) *	2010-12-13	2014-01-14	한국화학연구원	신규한 3-인돌리논 유도체 및 이를 포함하는 조성물
ES2570167T3 (es)	2011-03-16	2016-05-17	Probiodrug Ag	Derivados de benzimidazol como inhibidores de glutaminil ciclasa
AU2017370937A1 (en)	2016-12-07	2019-05-30	Biora Therapeutics, Inc.	Gastrointestinal tract detection methods, devices and systems
CA3045310A1 (en)	2016-12-14	2018-06-21	Progenity, Inc.	Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
EP3461819B1 (en)	2017-09-29	2020-05-27	Probiodrug AG	Inhibitors of glutaminyl cyclase
EP3883636A1 (en)	2018-11-19	2021-09-29	Progenity, Inc.	Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
EP3870261B1 (en)	2019-12-13	2024-01-31	Biora Therapeutics, Inc.	Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
EP4450494A1 (en) *	2023-04-20	2024-10-23	Consejo Superior De Investigaciones Científicas	Indole derivatives as histone deacetylase (hdac) inhibitors for the treatment of cancer

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3196162A (en) *	1961-03-13	1965-07-20	Merck & Co Inc	Indolyl aliphatic acids
GB957990A (en) *	1961-03-14	1964-05-13	Merck & Co Inc	Salts of substituted indoles
US3557142A (en)	1968-02-20	1971-01-19	Sterling Drug Inc	4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters
US3776923A (en)	1970-01-06	1973-12-04	American Cyanamid Co	2-nitro-4-oxo-4,5,6,7-tetrahydroindole
US3997557A (en)	1974-04-23	1976-12-14	American Hoechst Corporation	Substituted N-aminoalkylpyrroles
US4496742A (en)	1981-10-13	1985-01-29	The Upjohn Company	Analogs of 5,6-dihydro PGI2
FR2537974A1 (fr)	1982-12-16	1984-06-22	Adir	Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4529724A (en)	1983-10-11	1985-07-16	Mcneilab, Inc.	6H-indolo[2,1-c][1,4]benzodiazepines and 12-oxo derivatives useful as antihypertensives
FR2565981B1 (fr)	1984-06-15	1986-09-19	Adir	Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant
CA1241660A (en) *	1984-06-25	1988-09-06	Yvan Guindon	Indole-2-alkanoic acids
EP0190224A1 (en)	1984-07-30	1986-08-13	Schering Corporation	PROCESS FOR THE PREPARATION OF CIS, ENDOOCTAHYDROCYCLOPENTA [b] PYRROLE-2-CARBOXYLATE
US4675332A (en) *	1984-12-10	1987-06-23	Warner-Lambert Company	Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
DE3568431D1 (en)	1984-12-12	1989-04-06	Merck & Co Inc	Substituted aromatic sulfonamides, their preparation and ophthalmic compositions containing them
US4721725A (en)	1986-01-27	1988-01-26	E. R. Squibb & Sons, Inc.	Aryl-cycloalkyl[b]pyrrole derivatives
NZ222878A (en)	1986-12-17	1991-02-26	Merck Frosst Canada Inc	3-hetero-substituted-n-benzyl-indole derivatives, and pharmaceutical compositions
US4751231A (en)	1987-09-16	1988-06-14	Merck & Co., Inc.	Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
DE3907388A1 (de)	1989-03-08	1990-09-13	Kali Chemie Pharma Gmbh	Verfahren zur herstellung von indolcarbonsaeurederivaten
NZ234883A (en)	1989-08-22	1995-01-27	Merck Frosst Canada Inc	Quinolin-2-ylmethoxy indole derivatives, preparation and pharmaceutical compositions thereof
US5272145A (en)	1989-08-22	1993-12-21	Merck Frosst Canada, Inc.	(Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes
DD298913A5 (de)	1989-11-17	1992-03-19	Arzneimittelwerk Dresden Gmbh,De	Verfahren zur herstellung von n-substituierten 3-aminopyrrolen
DE3943225A1 (de)	1989-12-23	1991-06-27	Schering Ag	Neue ss-carboline, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5081145A (en) *	1990-02-01	1992-01-14	Merck Frosst Canada, Inc.	Indole-2-alkanoic acids compositions of and anti allergic use thereof
FR2679903B1 (fr) *	1991-08-02	1993-12-03	Elf Sanofi	Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.
US5260322A (en)	1990-10-08	1993-11-09	Merck & Co., Inc.	Angiotension II antagonists in the treatment of hyperuricemia
US5190968A (en)	1991-09-30	1993-03-02	Merck Frosst Canada, Inc.	(Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5273980A (en)	1991-09-30	1993-12-28	Merck Frosst Canada Inc.	Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5308850A (en)	1991-09-30	1994-05-03	Merck Frosst Canada, Inc.	(Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
CA2079374C (en)	1991-09-30	2003-08-05	Merck Frosst Canada Incorporated	(bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5389650A (en)	1991-09-30	1995-02-14	Merck Frosst Canada, Inc.	(Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5290798A (en)	1991-09-30	1994-03-01	Merck Frosst Canada, Inc.	(hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5318985A (en)	1991-12-20	1994-06-07	Merrell Dow Pharmaceuticals Inc.	Potentiation of NMDA antagonists
AU3488693A (en)	1992-02-13	1993-09-03	Merck Frosst Canada Inc.	(Azaaromaticalkoxy)indoles as inhibitors of leukotriene biosynthesis
FI944602A7 (fi)	1992-04-03	1994-10-03	Upjohn Co	Farmaseuttisesti aktiiviset bisyklis-heterosykliset amiinit
US5334719A (en)	1992-06-17	1994-08-02	Merck Frosst Canada, Inc.	Bicyclic(azaaromatic)indoles as inhibitors of leukotriene bisynthesis
US5288743A (en)	1992-11-20	1994-02-22	Abbott Laboratories	Indole carboxylate derivatives which inhibit leukotriene biosynthesis
ZA939516B (en)	1992-12-22	1994-06-06	Smithkline Beecham Corp	Endothelin receptor antagonists
US5852046A (en)	1993-08-03	1998-12-22	Hoechst Aktiengesellschaft	Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
EP0639573A1 (de)	1993-08-03	1995-02-22	Hoechst Aktiengesellschaft	Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
US5399699A (en)	1994-01-24	1995-03-21	Abbott Laboratories	Indole iminooxy derivatives which inhibit leukotriene biosynthesis
CN1166169A (zh)	1994-07-27	1997-11-26	三共株式会社	用作毒蕈碱性受体别构效应物的杂环化合物
US5482960A (en) *	1994-11-14	1996-01-09	Warner-Lambert Company	Nonpeptide endothelin antagonists
JPH10510538A (ja) *	1994-12-13	1998-10-13	スミスクライン・ビーチャム・コーポレイション	新規化合物
US5684032A (en)	1994-12-13	1997-11-04	Smithkline Beecham Corporation	Compounds
EA007107B1 (ru)	1995-04-04	2006-06-30	Инсизив Фармасьютикэлз Инк.	Тиенил- и дифенилсульфонамиды и их производные, модулирующие активность эндотелина
IT1282797B1 (it)	1995-04-21	1998-03-31	Colla Paolo	Pirril-(indolil)-aril-sulfoni e relativo processo di produzione ed impiego nella terapia delle infezioni da virus dell'aids
US5639780A (en) *	1995-05-22	1997-06-17	Merck Frosst Canada, Inc.	N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
US5604253A (en) *	1995-05-22	1997-02-18	Merck Frosst Canada, Inc.	N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
WO1997012613A1 (en)	1995-10-05	1997-04-10	Warner-Lambert Company	Method for treating and preventing inflammation and atherosclerosis
WO1997030704A2 (en)	1996-02-26	1997-08-28	Advanced Research And Technology Institute	Use of carbonic anhydrase inhibitors for treating macular edema
EP1021181A4 (en)	1996-03-28	2002-06-26	Smithkline Beecham Corp	INDOLCARBOXYLIC ACIDS AS CHEMOKIN INHIBITORS
US5859044A (en)	1996-07-31	1999-01-12	Pfizer Inc.	β-adrenergic agonists
EP0927167A1 (en)	1996-08-14	1999-07-07	Warner-Lambert Company	2-phenyl benzimidazole derivatives as mcp-1 antagonists
GB9716657D0 (en)	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
GB9716656D0 (en)	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
HU227568B1 (en) *	1997-12-24	2011-08-29	Sanofi Aventis Deutschland	Indole derivatives, as inhibitors os factor xa
GB9803228D0 (en)	1998-02-17	1998-04-08	Zeneca Ltd	Chemical compounds
GB9803226D0 (en)	1998-02-17	1998-04-08	Zeneca Ltd	Chemical compounds
GB9902461D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902459D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902455D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902453D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902452D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB0000626D0 (en)	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
GB0000625D0 (en)	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds

1999
- 1999-02-05 GB GBGB9902461.4A patent/GB9902461D0/en not_active Ceased
2000
- 2000-01-31 EE EEP200100403A patent/EE200100403A/xx unknown
- 2000-01-31 RU RU2001124567/04A patent/RU2235090C2/ru not_active IP Right Cessation
- 2000-01-31 KR KR1020017009862A patent/KR20010094755A/ko not_active Withdrawn
- 2000-01-31 US US09/889,599 patent/US6737435B1/en not_active Expired - Fee Related
- 2000-01-31 AU AU21213/00A patent/AU770856B2/en not_active Ceased
- 2000-01-31 IL IL14461100A patent/IL144611A0/xx unknown
- 2000-01-31 NZ NZ512680A patent/NZ512680A/en unknown
- 2000-01-31 TR TR2001/02233T patent/TR200102233T2/xx unknown
- 2000-01-31 DE DE60015296T patent/DE60015296T2/de not_active Expired - Lifetime
- 2000-01-31 WO PCT/GB2000/000265 patent/WO2000046196A1/en not_active Ceased
- 2000-01-31 AR ARP000100407A patent/AR022461A1/es not_active Application Discontinuation
- 2000-01-31 ID IDW00200101667A patent/ID30401A/id unknown
- 2000-01-31 HU HU0105079A patent/HUP0105079A3/hu unknown
- 2000-01-31 PL PL00350184A patent/PL350184A1/xx not_active Application Discontinuation
- 2000-01-31 BR BR0007984-7A patent/BR0007984A/pt not_active IP Right Cessation
- 2000-01-31 CA CA002356898A patent/CA2356898A1/en not_active Abandoned
- 2000-01-31 JP JP2000597267A patent/JP2002536359A/ja active Pending
- 2000-01-31 EP EP20000901259 patent/EP1150952B1/en not_active Expired - Lifetime
- 2000-01-31 AT AT00901259T patent/ATE280757T1/de not_active IP Right Cessation
- 2000-01-31 SK SK1115-2001A patent/SK11152001A3/sk unknown
- 2000-01-31 CN CN00803463A patent/CN1339025A/zh active Pending
- 2000-01-31 CZ CZ20012807A patent/CZ20012807A3/cs unknown
- 2000-02-04 MY MYPI20000404A patent/MY133209A/en unknown
2001
- 2001-06-26 IS IS5980A patent/IS5980A/is unknown
- 2001-06-27 ZA ZA200105311A patent/ZA200105311B/en unknown
- 2001-08-03 NO NO20013809A patent/NO20013809L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CZ20012807A3 (cs)	2001-10-17
CN1339025A (zh)	2002-03-06
RU2001124567A (ru)	2004-01-10
AR022461A1 (es)	2002-09-04
DE60015296T2 (de)	2006-02-02
PL350184A1 (en)	2002-11-18
EP1150952B1 (en)	2004-10-27
AU770856B2 (en)	2004-03-04
US6737435B1 (en)	2004-05-18
WO2000046196A1 (en)	2000-08-10
SK11152001A3 (sk)	2001-12-03
RU2235090C2 (ru)	2004-08-27
ID30401A (id)	2001-11-29
TR200102233T2 (tr)	2001-12-21
ATE280757T1 (de)	2004-11-15
ZA200105311B (en)	2002-09-27
GB9902461D0 (en)	1999-03-24
JP2002536359A (ja)	2002-10-29
AU2121300A (en)	2000-08-25
CA2356898A1 (en)	2000-08-10
IS5980A (is)	2001-06-26
DE60015296D1 (de)	2004-12-02
HUP0105079A2 (hu)	2002-04-29
MY133209A (en)	2007-10-31
HUP0105079A3 (en)	2002-11-28
NZ512680A (en)	2003-11-28
NO20013809D0 (no)	2001-08-03
IL144611A0 (en)	2002-05-23
BR0007984A (pt)	2001-11-06
NO20013809L (no)	2001-10-02
EP1150952A1 (en)	2001-11-07
KR20010094755A (ko)	2001-11-01

Publication	Publication Date	Title
EE200100403A (et)	2002-10-15	Indooli derivaadid ja nende kasutamine MCP-1 antagonistidena
EE200200251A (et)	2003-06-16	Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
EE200300244A (et)	2003-10-15	3-aroüülindooli derivaadid ja nende kasutamine CB2-retseptorite agonistidena
FI20002103A7 (fi)	2000-11-17	Amidijohdannaisia ja nosiseptiiniantagonisteja
DE60036803D1 (de)	2007-11-29	Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
DE60032601D1 (de)	2007-02-08	Als antikrebsmittel verwendbare heterocyklische derivate
DE60009147D1 (de)	2004-04-22	Admantan derivate
DE60032898D1 (de)	2007-02-22	Arylthiazolidindion- und aryloxazolidinderivate
ATE338021T1 (de)	2006-09-15	Substituierte 2-dialkylaminoalkylbiphenyl- derivate
PT1246816E (pt)	2004-08-31	Derivados de fenilpiperazina substituidos sua preparacao e utilizacao
EE200200204A (et)	2003-04-15	Asendatud bensimidasooli preparaat
EE200200135A (et)	2003-04-15	D4 antagonistidena toimivad tienoisoksasolüül- jatienüülpürrasolüülfenoksü-asendatud propüülderivaadid
DE60025918D1 (de)	2006-04-20	4-phenyl-pyrimidine derivate
DK1189583T3 (da)	2005-11-21	Indolderivater
IS6434A (is)	2002-06-19	Nýjar indól afleiður
DE60009931D1 (de)	2004-05-19	Muscarin-antagonisten
NO20004892D0 (no)	2000-09-29	Kinolin-4-yl-derivater I
NO20020306L (no)	2002-03-21	Indolderivater
NO20001718D0 (no)	2000-04-03	Benzen-fusjonerte heterocykliske derivater og anvendelse derav
IS6429A (is)	2002-06-19	Indólafleiður sem MCP-1 viðtakamótlyf
DE60012953D1 (de)	2004-09-16	3-amino-2-phenylpiperidinderivate als substanz p antagonisten
ATE362915T1 (de)	2007-06-15	Heterocyclische derivate und arzneistoffe
ATE260259T1 (de)	2004-03-15	Substituierte isochinolinderivate und ihre verwendung als anticonvulsiva
DE60118970D1 (de)	2006-05-24	Indol- und dihydroindolderivate
EE200200133A (et)	2003-04-15	Asendamata tienoisoksasoolfenoksüetüül- ja propüülderivaadid ning nende kasutamine D4 antagonistidena